Arcutis Biotherapeutics, Inc. (ARQT) › Net IncomeArcutis Biotherapeutics, Inc. (ARQT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$19.25M2019: -$42.00M2020: -$135.68M2021: -$206.36M2022: -$311.46M2023: -$262.14M2024: -$140.04M2025: -$16.14M-$16.14M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$16.14M+88.5%2024-$140.04M+46.6%2023-$262.14M+15.8%2022-$311.46M-50.9%2021-$206.36M-52.1%2020-$135.68M-223.1%2019-$42.00M-118.1%2018-$19.25M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share